Tesla, Solaredge, Palantir, Cleveland-Cliffs, Ocular: stocks are trending…

Tesla, Solaredge, Palantir, Cleveland-Cliffs, Ocular: stocks are trending…

Facebook
Twitter
LinkedIn

Major Wall Street indices closed over 1% higher on Monday Release of the consumer price index report on Tuesday. The Nasdaq Composite closed 1.48% higher, while the S&P 500 ended the session up 1.14%. The Dow Jones also closed 1.11% higher. Meanwhile, here are five stocks that are catching the attention of retail investors:

1. Tesla Inc TSLA: Tesla shares closed 1.14% lower on Monday. Analysts have warned that the EV company has lagged behind rivals in China in launching new models, improving navigation systems and introducing luxurious interiors or white-gloved customer service, Reuters reported.

Also read: Everything you need to know about Tesla stock

2. Palantir Technologies Inc PLTR: Shares of the data analysis software maker closed 1.33% higher and also gained 16.56% in extended trading. The company reported quarterly revenue of $508.62 million, beating analysts’ consensus estimate of $502.25 million. Palantir reported quarterly earnings of 4 cents per share beat analyst consensus estimate of 3 cents.

3. Solaredge Technologies Inc SEDG: Solaredge shares closed up 3.33% on Monday. The company reported quarterly earnings of $2.86 per share, beating analysts’ consensus estimate of $1.55. Solaredge reported quarterly revenue of $890.70 million Surpassed analysts’ consensus estimate of $879.23 million.

4. Cleveland Cliffs Inc. CLF: The company’s shares closed 0.85% higher but ended Monday’s session down 3.68%. For the fourth quarter of 2022, the Company reported a net loss of $204 million, representing a loss of $0.41 per diluted share compared to net income of $899 million, or $1.69 per diluted share for the year corresponds to the same period of the previous quarter.

5. Ocular Therapeutix, Inc. OKUL: The company’s shares closed up 35.14% on Monday. The company said its OTX TKIan axitinib intravitreal hydrogel implant indicated for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other…

[ad_2]

Source story

More to explorer